Cribstone Capital Management’s Medifast MED Stock Holding History

Cribstone Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$13K	–	652
2019 Q1	$13K	Hold	100	–	–	0.01%	435
2018 Q4	$13K	Hold	100	–	–	0.01%	433
2018 Q3	$22K	Hold	100	–	–	0.01%	390
2018 Q2	$16K	Hold	100	–	–	0.01%	429
2018 Q1	$9K	Hold	100	–	–	﹤0.01%	517
2017 Q4	$7K	Hold	100	–	–	﹤0.01%	626
2017 Q3	$6K	Hold	100	–	–	﹤0.01%	572
2017 Q2	$4K	Hold	100	–	–	﹤0.01%	616
2017 Q1	$4K	Hold	100	–	–	﹤0.01%	637
2016 Q4	$4K	Hold	100	–	–	﹤0.01%	599
2016 Q3	$4K	Hold	100	–	–	﹤0.01%	606
2016 Q2	$3K	Buy	+100	New	+$3.23K	﹤0.01%	659

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HCM

Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Cribstone Capital Management's MED Position: Q2 2019 in Review

Cribstone Capital Management sold out of Medifast (MED) in Q2 2019, closing a stake of 100 shares — an estimated $13K sold.

Cribstone Capital Management first reported a position in MED in Q2 2016 and held it in 12 quarters. The position peaked at $22K in Q3 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

Cribstone Capital Management reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
Cribstone Capital Management sold 100 Medifast shares in Q2 2019, an estimated $13K.
Cribstone Capital Management first reported a position in Medifast in Q2 2016 and held it in 12 quarters.
Cribstone Capital Management's Medifast position peaked at $22K in Q3 2018.
251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on Cribstone Capital Management's 13F filing for Q2 2019, filed 22 Jul 2019.